Regeneron Pharma (REGN) Price Target Raised to $410 at RBC

November 4, 2014 3:28 PM

RBC Capital maintained an Outperform rating on Regeneron Pharma (NASDAQ: REGN) and raised its price target to $410.00 (from $373.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found